Millipore Sigma Vibrant Logo

407254 IGFBP-3, CF, Mouse, Recombinant

View This Product on Sigma-Aldrich
407254
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

Purity
≥95% by SDS-PAGE

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
407254-25UGCN
在庫状況検索中…
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      ガラスビン 25 μg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewRecombinant, mouse insulin-like growth factor binding protein 3 (IGFBP-3) consisting of amino acids 22-291 and expressed in NS0-derived murine myeloma cells with four substitutions: Arg250Gln, Gln259Arg, Ser260Gly, Arg271Pro. Mouse IGFBP-3 cDNA encodes a 291 amino acid residue precursor protein with a putative 27 aa residue signal peptide.
      Catalogue Number407254
      Brand Family Calbiochem®
      References
      ReferencesSchuller, A.G.P., et al. 1994. Mol. Cell. Endoc. 104, 57.
      Product Information
      FormSolid
      FormulationLyophilized from 0.2 µm filtered Acetonitrile, TFA.
      Quality LevelMQ100
      Applications
      Biological Information
      Biological activityED₅₀ = 0.125-0.5 µg/ml as measured by inhibition of the biological activity of IGF-I or IGF-II (30 ng/ml) on MCF-7 human breast adenocarcinoma cells.
      Purity≥95% by SDS-PAGE
      Physicochemical Information
      ContaminantsEndotoxin: <1.0 EU/µg protein
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      407254-25UGCN 04055977188721

      Documentation

      IGFBP-3, CF, Mouse, Recombinant (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      IGFBP-3, CF, Mouse, Recombinant 試験成績書(CoA)

      タイトルロット番号
      407254

      参考資料

      参考資料の概要
      Schuller, A.G.P., et al. 1994. Mol. Cell. Endoc. 104, 57.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision13-September-2011 RFH
      DescriptionRecombinant, mouse insulin-like growth factor binding protein 3 (IGFBP-3) consisting of amino acids 22-291 and expressed in NS0-derived murine myeloma cells with four substitutions: Arg250Gln, Gln259Arg, Ser260Gly, Arg271Pro. Mouse IGFBP-3 cDNA encodes a 291 amino acid residue precursor protein with a putative 27 aa residue signal peptide.
      FormSolid
      FormulationLyophilized from 0.2 µm filtered Acetonitrile, TFA.
      Purity≥95% by SDS-PAGE
      ContaminantsEndotoxin: <1.0 EU/µg protein
      Biological activityED₅₀ = 0.125-0.5 µg/ml as measured by inhibition of the biological activity of IGF-I or IGF-II (30 ng/ml) on MCF-7 human breast adenocarcinoma cells.
      SolubilityReconstitute to 100 µg/ml in sterile PBS.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesSchuller, A.G.P., et al. 1994. Mol. Cell. Endoc. 104, 57.